中国是化学原料药生产大国，尤其是发酵类药物产品的产能产量位居世界第一，约占全球产量的 70%。而原料药生产过程中产生的“三废”量较大，废物成分复杂，污染危害严重，使得原料药企业面临的环保局势较为严峻，不断有药企因环保不达标被限产或停产。 2017 年 2 月起，环保部在北京、天津、河北、山西、山东、河南等地区开展空气质量专项督查。在本次环保部专项督查对象中，河北、山东是中国原料药及化工中间体主产区。河北省石家庄市作为原料药生产重镇印发了《 2017 年防治大气污染工作方案》。该方案明确指出，医药企业实施错峰生产、限产停产。 2016 年底，华北制药、石药集团等药企因“雾霾”停产而备受关注，现在又将迎来新一轮的生产调控。

Biliary stents have been in use since the 1970s to allow for biliary decompression. Biliary stents are mostly used for biliary infection cholangitis. The major obstruction in the biliary tree includes malignant and benign strictures, stenotic sphincters, obstructed endoprostheses, and bile duct stones. Colorectal cancer, which is one of the most diagnosed conditions and other conditions such as gallstones in the biliary duct, esophageal perforation, and bile duct injury requires stenting as a remedial or supplementary procedure.

医疗需求引进：推动健康医疗旅游发展，开发有特色的中医药健康旅游产品，提升医疗服务的国际化水平。医疗数据规范培养：培育健康医疗大数据应用新业态。加强健康体检的规范化管理。医疗国际竞争力培养：发展中医药健康服务。打造一批知名品牌和良性循环的健康服务产业集群，并形成一定的国际竞争力。国际旅行健康服务发展：开拓发展国际旅行健康服务。

One of the aspects of modern life that is considered as an essential by men and women is appearance. The desire to look presentable has led to the notable growth in the cosmetology industry. Originally, cosmetic surgery evolved from the reconstructive procedures and as a result, some of its techniques are similar whether they are used for reconstructive or cosmetic purposes. For instance, in various reconstructive procedures, breast implant is a procedure used to gain normal appearance after mastectomy. However, it has a much wider application in cosmetic technique to streamline the body shape.

Blood pressure transducers are used in blood pressure measurement when there are rapid changes in blood pressure due to cardiovascular instability, large fluid shifts, and pharmacological effects. In addition, non-invasive blood pressure monitoring devices are likely to, at times, be inaccurate in patients suffering from obesity, arterial fibrillation, and non-pulsatile blood flow during cardiopulmonary bypass, blood pressure monitoring with transducers is the appropriate option for blood pressure monitoring for accurate results. Blood pressure transducers are also used as a long-term option of measurement of blood pressure for individuals who are unwell as they avoid the need for repeated cuff inflation and allow repetitive sampling of blood gases for laboratory analysis.

Minimally invasive (MI) surgeries/procedures are rapidly becoming one of the leading approaches used to treat various cardiovascular ailments, especially blood clots. Over the years, majority of the MI cardiovascular surgeries have been increasingly using coronary stents, to increase the success rate of surgeries and reduce the procedure and recovery time. Coronary stents are used as an important component in percutaneous coronary revascularization. The use of coronary stents has enhanced the efficacy, and safety of stenting procedures.

A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions.A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).In this report, Technavio covers the present scenario and growth prospects of the global genomics biomarkers market for 2016-2021 (base year: 2016; forecast endyear: 2021). 

The global BGM devices market is growing due to the increase in the number of people with diabetes, especially type 1 diabetes. To avoid high doses of medication and insulin intake, these people are moving toward monitoring blood glucose levels by learning about the technicalities and the usage of BGM devices.

The global fluoropolymer market in the healthcare industry is forecast to grow at a CAGR of 7.19% during the forecast period because of the increase in the application of fluoropolymer in healthcare applications like pharmaceutical packaging, medical devices, drug delivery, and biological membranes.The pharmaceutical packaging application made up 38.23% of the global market share in 2015 and is expected to grow at a CAGR of 7.27% during 2016-2020. The drug delivery application has the highest expected growth rate with a CAGR of7.85%.Of the various types of fluoropolymers used in the healthcare industry,polytetrafluoroethylene (PTFE) registered the most demand, accounting for 54.5% of the global market in 2015. The share of this segment will grow at a CAGR of 6.77% during the forecast period. Other fluoropolymer products used in the healthcare industry will grow at a rate of 7.68%.Asia-Pacific (APAC) had both the leading market share, 34.6% in 2015, and the highest growth rate with a forecast CAGR of 7.64% during 2016-2020. The main reason for the region's dominance is the high availability of fluoropolymer raw materials here and the growing industrial and healthcare sectors in key countries like China, India, Japan, and South Korea.

The global immunodiagnostics market is in the moderate growth stage. The integration of mature clinical chemistry analyzers and restricted specificity and sensitivity of immunoassays have generated demand for integrated immunochemistry analyzers.The increasing volume of tests conducted due to rise in laboratory consolidation has driven the trend of automated analyzers globally.The Americas and Western European countries such as the UK, Germany, and France are major contributors to the market in terms of revenue generation. This is due to high level of automation in laboratories for high accuracy and efficiency.

药品一致性评价、医保支付方式改革和两票制等政策处于推进阶段，产业增长模式逐步重塑，制药业竞争回归至药品的治疗价值和质量水平，医药商业竞争回归物流管理和增值服务，小而散的格局将改变，市场份额将再分割，具备整体优势的龙头企业将获得更多的市场机会。

在2017年上半年，拥有强劲产品组合的药品生产商表现最为突出。我们相信，投资者将在2017年继续追捧这个投资主题，我们较看好能够受惠行业整合的龙头企业。对于2017年下半年，我们的首选是石药集团[1093.HK;买入]、东阳光药[1558.HK;买入]及中国中药[570.HK;买入]。